Catheter Precision, Inc. (VTAK) Net margin 2017–2025
Catheter Precision, Inc. (VTAK) net profit margin by fiscal year — reported net income divided by reported revenue.
-2098.0%FY2025 · since FY2017: -302.6% → -2098.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2098.0% | +1864.6 pp |
| FY2024 | -3962.6% | +12003.9 pp |
| FY2023 | -15966.5% | +175926.3 pp |
| FY2022 | -191892.9% | -77938.3 pp |
| FY2021 | -113954.5% | -100037.6 pp |
| FY2020 | -13917.0% | -13125.8 pp |
| FY2019 | -791.2% | -298.4 pp |
| FY2018 | -492.8% | -190.1 pp |
| FY2017 | -302.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VTAK financial trends
VTAK RevenueVTAK Net incomeVTAK Gross profitVTAK Gross marginVTAK Operating incomeVTAK Operating marginVTAK Operating cash flowVTAK Free cash flowVTAK Capital expendituresVTAK Return on equityVTAK Stock buybacksVTAK Dividends paidVTAK Total assetsVTAK Total liabilitiesVTAK Shareholders’ equityVTAK overview →